Vertigo

Advanced Clinical and Pathophysiological Insights into Vertigo

Synonyms for vertigo include:

• Dizziness
• Lightheadedness
• Disequilibrium
• Spinning sensation
• Giddiness
• Unsteadiness
• Motion sickness
• Balance disorder

These terms may be used interchangeably in certain contexts, though "vertigo" specifically refers to a false sensation of movement, often rotational.

Vertigo, a subtype of dizziness, is characterized by an illusory sensation of movement, typically rotational, despite the absence of actual environmental motion. This distressing phenomenon significantly impairs functional capacity, necessitating an in-depth understanding of its varied etiologies, pathophysiological mechanisms, and therapeutic strategies. Given the increasing prevalence of vertigo-related disorders, recent advances in neuro-otology and vestibular rehabilitation demand a thorough exploration. This document provides an extensive analysis of vertigo, its classification, pathogenesis, differential diagnosis, and emerging trends in its management.

Image source Google

Classification of Vertigo

Vertigo is broadly categorized into two primary types:

1. Peripheral Vertigo: This type originates from dysfunction within the vestibular apparatus, including the semicircular canals, otolithic organs, or the vestibulocochlear nerve. Conditions such as Benign Paroxysmal Positional Vertigo (BPPV), Ménière’s disease, and vestibular neuritis fall under this classification.

2. Central Vertigo: Resulting from abnormalities within the brainstem or cerebellum, central vertigo is commonly associated with vestibular migraine, cerebrovascular events, multiple sclerosis, and neoplasms affecting central vestibular pathways.

Etiopathogenesis

Peripheral Vertigo

• Benign Paroxysmal Positional Vertigo (BPPV): The fundamental pathophysiological mechanism of BPPV involves the displacement of otoconia into the semicircular canals, leading to aberrant endolymphatic flow. This inappropriate stimulation of vestibular afferents results in transient vertiginous episodes triggered by head movements.

• Ménière’s Disease: Thought to arise from endolymphatic hydrops, Ménière’s disease leads to episodic vertigo, fluctuating hearing loss, tinnitus, and aural fullness. Proposed mechanisms include impaired endolymphatic resorption, genetic susceptibility, and autoimmune contributions.

• Vestibular Neuritis: Often linked to viral infections, particularly reactivation of latent herpes simplex virus, vestibular neuritis induces acute vestibular dysfunction. The inflammatory process primarily affects the superior vestibular nerve, resulting in spontaneous vertigo without auditory symptoms.

Image source Google

Central Vertigo

• Vestibular Migraine: Characterized by the interplay of cortical, subcortical, and brainstem dysfunction, vestibular migraine involves complex interactions between trigeminovascular pathways and central vestibular circuits. Neuroinflammatory mechanisms and sensory hypersensitivity contribute to episodic vertigo, often in conjunction with migraine headaches.

• Cerebrovascular Causes: Ischemic or hemorrhagic strokes involving the posterior circulation, particularly the vertebrobasilar system, can impair central vestibular integration. Isolated vertigo may be a heralding symptom of a major cerebrovascular event, underscoring the importance of prompt evaluation.

• Multiple Sclerosis (MS): Demyelinating lesions affecting the brainstem or cerebellum disrupt vestibular signal integration, leading to episodic or chronic vertigo. MS-related vertigo may be accompanied by diplopia, dysarthria, or limb ataxia.

Differential Diagnosis

Distinguishing vertigo from other causes of dizziness is essential for accurate diagnosis:

• Presyncope: Often due to cardiovascular conditions causing transient cerebral hypoperfusion.
• Disequilibrium: Frequently associated with proprioceptive deficits, cerebellar dysfunction, or musculoskeletal pathology.
• Non-specific Dizziness: Often psychogenic or systemic in origin, lacking true rotational vertigo.

Additional differentials include:

• Labyrinthitis: Involves simultaneous auditory and vestibular symptoms due to inner ear infection.
• Acoustic Neuroma: A vestibular schwannoma can cause progressive hearing loss and imbalance.
• Cervical Vertigo: Dysfunction of the cervical spine impacting proprioceptive input to the vestibular system.

Clinical Evaluation and Diagnostic Approach

History and Examination

A comprehensive history should assess symptom duration, triggers, auditory involvement, headache correlation, and autonomic features. Physical examination should include:

• Neurological Examination: Cranial nerve testing, cerebellar function assessment, and Romberg’s test.
• Vestibular Function Tests:
  • Dix-Hallpike Maneuver: Confirms posterior canal BPPV by eliciting characteristic nystagmus.
  • Head Impulse Test (HIT): Identifies vestibulo-ocular reflex deficits in peripheral disorders.
  • Audiometry: Essential in Ménière’s disease and acoustic neuroma evaluation.
  • Neuroimaging: MRI with diffusion-weighted imaging is crucial for excluding central causes.
  • Vestibular Evoked Myogenic Potentials (VEMP): Assesses otolith organ function.

Management Strategies

Peripheral Vertigo

• BPPV:

  • Canalith Repositioning Maneuvers: Epley maneuver remains the first-line treatment.
  • Vestibular Rehabilitation Therapy (VRT): Facilitates central adaptation.
  • Medications: Vestibular suppressants such as Meclizine (25-50 mg orally every 6 hours as needed for acute episodes).

• Ménière’s Disease:

  • Dietary and Pharmacological Modifications: Sodium restriction, diuretics, and betahistine (24-48 mg per day in divided doses).
  • Intratympanic Therapy: Corticosteroid injections (e.g., dexamethasone 4 mg/mL) or gentamicin for refractory cases.
  • Surgical Options: Vestibular nerve section in intractable disease.

• Vestibular Neuritis:

  • Acute Management: Corticosteroids (Prednisolone 60 mg/day for 7-10 days) and vestibular suppressants (Diazepam 2-5 mg twice daily as needed for severe vertigo).
  • Long-Term Therapy: Vestibular rehabilitation for persistent imbalance.

Central Vertigo

• Vestibular Migraine:

  • Prophylaxis: Beta-blockers (Propranolol 40-160 mg/day), calcium channel blockers, and tricyclic antidepressants (Amitriptyline 10-50 mg at bedtime).
  • Acute Therapy: Triptans (Sumatriptan 50-100 mg orally at onset of migraine).

• Stroke-Related Vertigo:

  • Acute Intervention: Thrombolysis (Alteplase 0.9 mg/kg IV within 4.5 hours of stroke onset) or mechanical thrombectomy.
  • Secondary Prevention: Antiplatelets (Aspirin 81-325 mg daily), statins (Atorvastatin 40-80 mg/day), and lifestyle modifications.

Consultation and Emerging Trends

• Multidisciplinary Management: Collaboration among otolaryngologists, neurologists, and physical therapists enhances patient outcomes.
• Innovations in Therapy:
  • Vestibular Neuromodulation: Transcranial magnetic stimulation for vestibular compensation.
  • Wearable Vestibular Monitoring: Enables real-time patient tracking.
  • Artificial Intelligence (AI): Enhancing vestibular diagnostics via machine learning algorithms.

Key Takeaways

• BPPV is highly responsive to canalith repositioning.
• Ménière’s disease necessitates comprehensive management, including dietary, pharmacological, and surgical approaches.
• Central vertigo requires urgent neuroimaging to exclude cerebrovascular pathology.
• AI and wearable technology are revolutionizing vertigo assessment and treatment.

References

1. Baloh RW, Honrubia V. Clinical Neurophysiology of the Vestibular System. 4th ed. Oxford University Press; 2020.
2. Furman JM, Cass SP. Vestibular Disorders: A Case-Study Approach. 2nd ed. Oxford University Press; 2019.
3. Neuhauser HK. Epidemiology of Vertigo. Neuroepidemiology. 2021;57(2):85-90.
4. Strupp M, Lopez-Escamez JA. Advances in Vestibular Medicine. Lancet Neurol. 2022;21(4):287-300.